<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13846">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02926664</url>
  </required_header>
  <id_info>
    <org_study_id>DeltaSCREEN</org_study_id>
    <nct_id>NCT02926664</nct_id>
  </id_info>
  <brief_title>Delta qSOFA for Risk Stratification in Emergency Infected Patients</brief_title>
  <acronym>DELTASCREEN</acronym>
  <official_title>Prognostic Value of Quick Sequential Organ Failure Assessment Kinetics After Fluids Challenge in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Societe Française de Medecine d'urgence</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Societe Française de Medecine d'urgence</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate the prognostic value of qSOFA (quick Sequential Organ Failure
      Assessment) kinetics between H0 and H1, and between H0 and H3 in patients with suspicion of
      Sepsis, i.e. an initial qSOFA of at least of 2.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      qSOFA has been reported as a good tool for risk stratification in the ED for patients with
      infection.

      However, it is not clear whether qSOFA remains stable during the ED stay, nor whether its
      kinetics can have prognostic added value.

      Patients with a qSOFA of at least 2 in the ED, and suspicion of infection will be included.

      After treatment is initiated and fluids challenge performed, we will collect qSOFA value at
      1 hour and 3 hours.

      Our hypothesis is that a decrease in qSOFA between H0 and H1 is associated with better
      outcome. We assume that 50% of patients will have a deltaqSOFA &gt;0, with an overall mortality
      of 23% (according to previous cohort). Under the hypothesis of difference of at least 15% in
      mortality between the two groups (DeltaqSOFA &gt; 0 and Delta qSOFA&lt;=0), with a power of 90%
      and an alpha of 0.05, we need to recruit 322 patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU admission more than 72 hours</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU admission</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">322</enrollment>
  <condition>Sepsis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>measurement of qSOFA</intervention_name>
    <description>qSOFA will be measured at H0, H1 and H3</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients in the ED who presents with suspicion of infection AND a qSOFA of at least
        2.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  suspicion of infection by the emergency physicians

          -  at least two of the following criteria : respiratory rate &lt;= 22, systolic blood
             pressure &lt;= 100 mmHg and altered mental status

        Exclusion Criteria:

          -  Infection ruled out by the expert after chart review

          -  patient who refuse to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yonathan Freund</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emergency Department - hopital pitie salpetriere, Paris, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yonathan Freund, MD, PhD</last_name>
    <phone>+33184827129</phone>
    <email>yonathan.freund@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques St Luc</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Penaloza</last_name>
      <email>andrea.penaloza@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Nimes</name>
      <address>
        <city>Nimes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Geraud Claret</last_name>
      <email>pierre.geraud.claret@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cochin</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence Dumas</last_name>
      <email>florence.dumas@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Europeen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Laure Feral-Pierssens</last_name>
      <email>feralal@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yonathan Freund</last_name>
      <email>yonatman@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Tenon</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Pernet</last_name>
      <email>julie.pernet@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lariboisière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Truchot</last_name>
      <email>jennifer.truchot@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youri Yordanov</last_name>
      <email>youri.yordanov@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierrick Le Borgne</last_name>
      <email>pierrick.le-borgne@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mar Ortega</last_name>
      <email>mortega@clinic.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 21, 2016</lastchanged_date>
  <firstreceived_date>October 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Societe Française de Medecine d'urgence</investigator_affiliation>
    <investigator_full_name>Yonathan Freund</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>data will be available upon request to the principal investigator</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
